News from us and our partners

Tags

Topics

0 results

News
28 June, 2024
Redx Reports encouraging Zamaporvint (RXC004) Phase 2 combination data in MSS mCRC at ESMO GI Congress supporting genetic selection hypothesis in hard-to-treat GI Cancers
News
27 June, 2024
Chroma Medicine announces exclusive license agreement with the Whitehead Institute for Novel Epigenetic Editing Technology
News
27 June, 2024
Sensorion appoints Laurene Danon as CFO
News
26 June, 2024
Crescendo Biologics announces that Zai Lab has initiated a global Phase 2 clinical trial evaluating ZL-1102 (Humabody®, CB001) as a topical treatment for psoriasis
News
18 June, 2024
BrightHeart appoints Michael Butchko as Chairman of the Board
News
17 June, 2024
Meiogenix hires Ricardo Garcia de Alba as CEO
News
12 June, 2024
NodThera meets primary endpoint in Phase 1b/2a trial
News
12 June, 2024
T-Therapeutics appoints Dr. David Hung as Chairman
News
12 June, 2024
Danone, DMC, Michelin and Crédit Agricole Centre France join forces to create a cutting-edge biotechnology platform
News
7 June, 2024
SafeHeal's Colovac wins FDA Breakthrough Device designation
News
5 June, 2024
Moon Surgical receives second FDA clearance, covering its commercial Maestro™ surgical robotics system
News
4 June, 2024
Afyren provides business update on its Afyren Neoxy plant
News
3 June, 2024
HighLife receives IDE approval to initiate US pivotal clinical study for treatment of mitral regurgitation
News
3 June, 2024
GenSight Biologics appoints William Monteith to its Board of Directors
News
31 May, 2024
Johnson & Johnson completes acquisition of Shockwave Medical
News
28 May, 2024
Asahi Kasei to acquire Calliditas Therapeutics AB to accelerate growth as a global healthcare company

Redx Reports encouraging Zamaporvint (RXC004) Phase 2 combination data in MSS mCRC at ESMO GI Congress supporting genetic selection hypothesis in hard-to-treat GI Cancers

Chroma Medicine announces exclusive license agreement with the Whitehead Institute for Novel Epigenetic Editing Technology

Sensorion appoints Laurene Danon as CFO

Crescendo Biologics announces that Zai Lab has initiated a global Phase 2 clinical trial evaluating ZL-1102 (Humabody®, CB001) as a topical treatment for psoriasis

BrightHeart appoints Michael Butchko as Chairman of the Board

Meiogenix hires Ricardo Garcia de Alba as CEO

NodThera meets primary endpoint in Phase 1b/2a trial

T-Therapeutics appoints Dr. David Hung as Chairman

Danone, DMC, Michelin and Crédit Agricole Centre France join forces to create a cutting-edge biotechnology platform

SafeHeal's Colovac wins FDA Breakthrough Device designation

Moon Surgical receives second FDA clearance, covering its commercial Maestro™ surgical robotics system

Afyren provides business update on its Afyren Neoxy plant

HighLife receives IDE approval to initiate US pivotal clinical study for treatment of mitral regurgitation

GenSight Biologics appoints William Monteith to its Board of Directors

Johnson & Johnson completes acquisition of Shockwave Medical

Asahi Kasei to acquire Calliditas Therapeutics AB to accelerate growth as a global healthcare company